Filing Flows › Iradimed (IRMD) › Q1 2025
Iradimed (IRMD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 5, 2025
Iradimed (IRMD) reported revenue of $19.5M for the first quarter 2025 (Q1 2025), +11% from a year earlier and +0.6% from the quarter before. Operating margin was 27.8%, net earnings $4.7M (24.0% of revenue).
Iradimed, Q1 2025: revenue $19.5M (+11% year over year), operating margin 27.8%, net earnings $4.7M, operating cash flow $4.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.5M | +0.6% | +11% |
| Gross profit | $14.8M | +0.6% | +11% |
| Operating profit | $5.4M | -6% | +14% |
| Net earnings | $4.7M | -9% | +13% |
| Operating cash flow | $4.3M | -28% | +11% |
| Free cash flow | $375K | — | -89% |
What changed
Revenue was $19.5M in Q1 2025, up 11% year over year and up 1% from the previous quarter.
Gross margin was 76.1%, unchanged from a year earlier. Operating profit was $5.4M, a 27.8% margin (up 0.9 points year over year). Of the extra revenue versus a year earlier, 36% reached operating profit, above the 27% margin then. Operating expenses grew 9% against revenue growth of 11%. The fastest-growing cost line was General & admin (+16%). Net earnings were $4.7M, up 13% year over year. The effective tax rate was 21.2%.
Operating cash flow was $4.3M (up 11% year over year), 92% of net earnings. Non-cash charges added back $194K of depreciation and amortization and $826K of share-based compensation. Working capital and other items used $1.4M. After capital Expenditures ($3.9M), free cash flow as the company reports it was $375K.
Questions
What was Iradimed's revenue in the first quarter 2025?
Iradimed (IRMD) reported revenue of $19.5M for the first quarter 2025 (Q1 2025), +11% from a year earlier and +0.6% from the quarter before.
Was Iradimed profitable in the first quarter 2025?
Operating profit was $5.4M (27.8% of revenue) and net earnings $4.7M.
Source: Iradimed 10-Q on SEC EDGAR.